NCT02335112View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Head and Neck Neoplasms
Interventions
PROCEDURE

Irreversible electroporation (IRE)

Irreversible Electroportion For Unresectable Head and Neck Neoplasms guide with ultrasound or/and CT.

DEVICE

NanoKnife

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02335112 - Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms | Biotech Hunter | Biotech Hunter